Clinical Chemistry Conference

Overview:

The conference aims to offer new advancements, diagnostic technologies and different use of biomarkers in identifying Alzheimer’s and acute kidney injuries and key elements for success of POCT testing quality assurance. Clinical chemistry conference will bring in experts from around the world to share their expertise and advances in new testing and techniques. 

Key topics:

• What is new with eGFR 
• Alzheimer’s disease biomarkers 
• Key elements for the successful implementation of a Point of Care Program  
  

Benefits of attending:

• Understand the new calculation of eGFR for blood testing of creatinine levels   
• Review how CSF biomarker can help diagnose early detection of Alzheimer’s 
  
• Discuss best practices in POCT for rapid diagnostic and screening test results 
  

Scientific Co-Chairs:

• Dr Fayha Ahmed, Consultant and Head of Biochemistry Unit, Pathology & Genetics Department, Dubai Hospital, Dubai, UAE
• Dr Laila AbdelWareth, CEO, National Reference Laboratory (NRL); Chair, Clinical Pathology, Cleveland Clinic Abu Dhabi, President, Emirates Clinical Chemistry Society, Dubai, UAE